463 related articles for article (PubMed ID: 20140275)
1. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[TBL] [Abstract][Full Text] [Related]
2. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Hun L
Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
4. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
6. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
7. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
8. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Ali F; Pande A; Majeed S; Karri SK
Nutr J; 2016 Feb; 15():21. PubMed ID: 26922379
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
Simrén M; Ohman L; Olsson J; Svensson U; Ohlson K; Posserud I; Strid H
Aliment Pharmacol Ther; 2010 Jan; 31(2):218-27. PubMed ID: 19863495
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
11. Temporary sacral nerve stimulation for treatment of irritable bowel syndrome: a pilot study.
Lundby L; Krogh K; Buntzen S; Laurberg S
Dis Colon Rectum; 2008 Jul; 51(7):1074-8. PubMed ID: 18418655
[TBL] [Abstract][Full Text] [Related]
12. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
13. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
Tuteja AK; Fang JC; Al-Suqi M; Stoddard GJ; Hale DC
Scand J Gastroenterol; 2012 Oct; 47(10):1159-64. PubMed ID: 22783919
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
16. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
18. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]